# Fetal Alcohol Spectrum Disorder : Clinical Description and Search for Epigenetic Biomarker (EPI-TSAF)

> **NCT06471335** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de la Réunion** · enrollment: 188 (actual)

## Conditions studied

- Fetal Alcohol Spectrum Disorders

## Interventions

- **DIAGNOSTIC_TEST:** Extraction of microRNAs extracted from plasma (4 ml recovered as part of treatment)
- **DIAGNOSTIC_TEST:** Extraction of microRNAs extracted from bucal swabs (act added for research).

## Key facts

- **NCT ID:** NCT06471335
- **Lead sponsor:** Centre Hospitalier Universitaire de la Réunion
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-12
- **Primary completion:** 2024-10-22
- **Final completion:** 2024-10-23
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471335, "Fetal Alcohol Spectrum Disorder : Clinical Description and Search for Epigenetic Biomarker (EPI-TSAF)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06471335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*